What is the best treatment for post nasal drip in a 13-month-old patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Post-Nasal Drip in a 13-Month-Old

For a 13-month-old with post-nasal drip, use nasal saline irrigation as the primary treatment, as this is the only intervention with any supporting evidence in young children and carries minimal risk. 1

Primary Treatment Approach

Nasal Saline Irrigation

  • Saline nasal irrigation is the safest and most appropriate first-line therapy for infants and toddlers with post-nasal drip. 1
  • While the evidence quality is very low, one small study found larger effects with high-volume versus low-volume saline rinsing specifically for purulent rhinorrhea and post-nasal drip. 1
  • Saline can be expected to be beneficial rather than harmful on theoretical grounds, as it helps thin secretions and mechanically clear mucus. 1
  • Use isotonic saline drops or gentle spray formulations appropriate for infants, applied 2-4 times daily or as needed. 1

What NOT to Use in This Age Group

Intranasal Corticosteroids - Age Restriction

  • Mometasone furoate (Nasonex) is FDA-approved only for children ≥2 years of age. 1
  • At 13 months, this child is too young for mometasone, which requires a minimum age of 2 years (dosing would be 1 spray per nostril daily = 100 mcg total for ages 2-11 years). 1, 2
  • Fluticasone furoate (Veramyst) and triamcinolone acetonide (Nasacort) are also approved only for ≥2 years. 1
  • Fluticasone propionate (Flonase) is approved for ≥4 years. 1

Antihistamines - No Evidence in Children

  • The EPOS 2020 guidelines found one study evaluating antihistamines in children with post-viral rhinosinusitis showing no additive benefit over placebo. 1
  • Based on very low quality evidence, antihistamines cannot be recommended for post-nasal drip in young children. 1

Antibiotics - Not Indicated

  • Antibiotics are not associated with greater cure or significant improvement in children with acute post-viral rhinosinusitis and should not be used. 1
  • Post-viral rhinosinusitis is self-limiting, and the EPOS 2020 steering group advises against antibiotic use in children for this condition. 1

Clinical Approach Algorithm

  1. Confirm the diagnosis: Post-nasal drip in infants typically manifests as throat clearing, cough (especially when lying down), irritability during feeding, or visible mucus in the posterior pharynx. 3, 4

  2. Identify the underlying cause: Common etiologies in this age group include:

    • Viral upper respiratory infections (most common) 1
    • Adenoid hypertrophy (though less common at 13 months) 5
    • Allergic rhinitis (less likely at this age but possible) 5
    • Gastroesophageal reflux (consider if feeding-related symptoms present) 4
  3. Initiate saline irrigation: Use age-appropriate saline drops or gentle spray 2-4 times daily, particularly before feeds and sleep. 1

  4. Provide supportive care: Elevate the head of the crib slightly, use a cool-mist humidifier, and ensure adequate hydration. 3

  5. Reassess in 2-3 weeks: If symptoms persist beyond typical viral illness duration (10-14 days) or worsen, consider referral to pediatric otolaryngology to evaluate for structural causes like adenoid hypertrophy. 4, 5

Important Caveats

  • Most post-nasal drip in infants is self-limiting and related to viral upper respiratory infections. 1
  • The sensation of post-nasal drip may not correlate with actual visible secretions on examination. 4, 6
  • Persistent symptoms beyond 3-4 weeks, unilateral symptoms, or associated warning signs (failure to thrive, recurrent infections, breathing difficulties) warrant specialist evaluation. 4
  • Avoid over-the-counter cough and cold medications in children under 2 years due to safety concerns and lack of efficacy. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nasonex Dosing for Post-Nasal Drip

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The management of postnasal drip.

Australian family physician, 1999

Research

The patient with "postnasal drip".

The Medical clinics of North America, 2010

Research

[Analysis the causes and treatment of postnasal drip syndrome].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.